You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 29, 2025

Profile for Ukraine Patent: 99924


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Ukraine Patent: 99924

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jan 30, 2029 Theracosbio BRENZAVVY bexagliflozin
⤷  Get Started Free Aug 22, 2028 Theracosbio BRENZAVVY bexagliflozin
⤷  Get Started Free Aug 22, 2028 Theracosbio BRENZAVVY bexagliflozin
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Ukraine Drug Patent UA99924

Last updated: July 31, 2025

Introduction

Patent UA99924 is a critical intellectual property asset within Ukraine’s pharmaceutical patent landscape. An in-depth review of its scope, claims, and overall patent environment provides vital insights for industry stakeholders, including innovators, generic manufacturers, regulatory bodies, and legal professionals aiming to navigate the Ukrainian pharmaceutical patent landscape effectively.

This analysis dissects UA99924’s scope by examining its claims, strategic positioning, and associated patent landscape. It also evaluates how the patent fits within broader regional and global frameworks, considering pertinent legal and commercial factors.


Overview of Ukraine Patent UA99924

UA99924 is a Ukrainian patent granted for a specific pharmaceutical invention—presumably a novel drug compound, formulation, or delivery method—filed and prosecuted under Ukraine’s national patent regulations. While detailed specifications require direct review of the patent document, publicly available patent notices suggest its focus on a particular active ingredient or a unique pharmaceutical composition.

Note: Exact technical details are often proprietary, but the scope can typically be inferred from the claims’ language and classification data.


Scope of Patent UA99924

Claims Analysis

Patent claims are the defining legal boundaries of a patent. They determine the scope of patent protection. Typically, such patents include independent claims, which establish broad coverage, and dependent claims, which specify particular embodiments or variations.

Based on the typical structure of pharmaceutical patents, UA99924 likely incorporates:

  • Compound Claims: Covering a specific chemical entity or class of compounds.
  • Composition Claims: Protecting a formulation comprising the active ingredient and excipients.
  • Method Claims: Encompassing methods of preparing, administering, or using the compound or composition.
  • Use Claims: Covering novel therapeutic uses of the compound.

Hypothetical Example:

  • Independent Compound Claim:
    "A compound selected from the group consisting of [specific chemical structure], characterized by [specific features], suitable for use in the treatment of [specific medical condition]."

  • Dependent Claims: Cover various derivatives, salts, esters, or specific salts, modifications in preparation, or dosing regimes.

Scope Breadth and Limitations

The breadth of the claims directly influences the patent's enforceability:

  • Broad Claims: Cover a wide range of chemical structures or therapeutic uses, offering broad protection but potentially more susceptible to validity challenges.
  • Narrow Claims: Focus on specific compounds or methods, which might be easier to defend but limit commercial exclusivity.

If UA99924 is a composition or use patent, it might present a narrower scope but still offer valuable exclusivity over competing formulations or indications.


Patent Landscape and Strategic Positioning

Regional and International Context

Ukraine’s patent system aligns broadly with international standards, incorporating the European Patent Convention (EPC) principles. UA99924’s patent family status, surface-level searches, and regional filings suggest its strategic aim to establish patent protection domestically and potentially in neighboring markets.

  • Parallel Patents: Many pharmaceutical inventions benefit from filing in multiple jurisdictions—e.g., EU, Eurasia, and Russia. The presence or absence of such filings influences UA99924’s regional exclusivity.

  • Patent Family Status: If UA99924 forms part of an international patent family, its scope likely spans multiple jurisdictions, enhancing market control.

Prior Art Consideration

The patent’s validity hinges on its novelty and inventive step:

  • Prior Art Search: Involves chemical databases, patent databases (e.g., EAPAT, Ukraine Patent Office), and scientific literature. Evidence of pre-existing similar compounds or formulations challenges the novelty.

  • Implication for Competitors: Broad claims not supported by prior art can extend exclusivity. Conversely, overlapping prior art might lead to limited enforceability.

Potential Challenges

  • Patent Clarity and Support: Ukrainian patent law requires claims to be clear and supported by the description. Overly broad or unsupported claims risk invalidation.

  • Patent Term and Maintenance: Patent durations extend typically 20 years from filing, assuming regular maintenance fees are paid. The lifecycle impacts market exclusivity.


Legal and Commercial Implications

Enforcement Landscape

Enforcement within Ukraine depends on the robustness of the patent claims and legal proceedings. Patent infringement actions focus on proving that a competitor’s product falls within the scope of the patent claims.

Market Impact

If UA99924 covers a novel, patentable compound, it provides a significant competitive advantage: monopoly over manufacturing, licensing opportunities, and pricing control. Conversely, narrow claims or invalidation could open avenues for generics.

Innovation Strategies

Patent holders often supplement patent protection with supplementary data rights, regulatory exclusivities, and market strategies to maximize innovation value.


Conclusion

Patent UA99924 embodies a strategically designed invention tailored for Ukrainian pharmaceutical markets. Its scope hinges on the precise language of its claims—whether broad or narrow—and the associated patent landscape indicates potential for regional protection and commercialization.

The patent’s strength depends on the novelty, inventive step, and clarity of its claims, alongside the ability to defend it against legal challenges. The broader patent landscape, including regional filings and prior art considerations, shapes its enforceability.


Key Takeaways

  • Claims Define Protection: The scope of UA99924 primarily depends on its independent claims’ breadth, influencing market exclusivity.
  • Strategic Filing: Regional and international patent family filings expand territorial protection and market control.
  • Validity Factors: Validity depends on novelty and inventive step assessments, necessitating thorough prior art searches.
  • Enforcement Readiness: A robust patent claim structure enhances enforceability within Ukraine.
  • Complementary Strategies: Patent protection combined with regulatory exclusivities amplifies commercial rights.

FAQs

  1. What is the significance of patent claims in pharmaceutical patents?
    Claims delineate the legal boundaries of a patent, determining what inventions are protected and how infringement is assessed.

  2. How can I verify the scope of UA99924’s protection?
    By analyzing its published claims, technical description, and any available patent certificates, ideally through a patent attorney or database search.

  3. What factors influence the validity of UA99924 in Ukraine?
    The invention’s novelty, inventive step, clarity, support in the description, and absence of prior art impacting these elements.

  4. Can UA99924 be challenged or invalidated?
    Yes, through opposition procedures, validity challenges, or legal disputes if prior art indicates lack of novelty or inventive step.

  5. What strategic options exist for patent holders of UA99924?
    They can enforce rights against infringers, seek licensing agreements, and pursue additional patents or extensions to strengthen market position.


References

  1. Ukrainian Patent Law and Regulations. (Official Ukrainian Patent Office publications).
  2. WIPO PATENTSCOPE and EAPAT databases for prior art and patent family information.
  3. Regional patent filings and classifications relevant to UA99924.
  4. Case law and legal commentary on Ukrainian pharmaceutical patent enforcement.

Note: Due to limited publicly available data specific to UA99924, this analysis provides a structural overview based on standard patent principles and typical pharmaceutical patent characteristics within Ukraine. For precise legal assessment, direct review of the patent document and legal consultation are recommended.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.